Authors:
NILSSON D
HANSSON LE
JOHANSSON K
NYSTROM C
PAALZOW L
AQUILONIUS SM
Citation: D. Nilsson et al., LONG-TERM INTRADUODENAL INFUSION OF A WATER-BASED LEVODOPA-CARBIDOPA DISPERSION IN VERY ADVANCED PARKINSONS-DISEASE, Acta neurologica Scandinavica, 97(3), 1998, pp. 175-183
Citation: E. Bredberg et al., PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA IN RATS FOLLOWING DIFFERENT ROUTES OF ADMINISTRATION, Pharmaceutical research, 11(4), 1994, pp. 549-555
Authors:
BREDBERG E
NILSSON D
JOHANSSON K
AQUILONIUS SM
JOHNELS B
NYSTROM C
PAALZOW L
Citation: E. Bredberg et al., INTRADUODENAL INFUSION OF A WATER-BASED LEVODOPA DISPERSION FOR OPTIMIZATION OF THE THERAPEUTIC EFFECT IN SEVERE PARKINSONS-DISEASE, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 117-122
Authors:
ASHTON M
BOLME P
ALEMAYEHU E
ERIKSSON M
PAALZOW L
Citation: M. Ashton et al., DECREASED CHLORAMPHENICOL CLEARANCE IN MALNOURISHED ETHIOPIAN CHILDREN, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 181-186
Citation: M. Ekblom et al., MODELING OF TOLERANCE DEVELOPMENT AND REBOUND EFFECT DURING DIFFERENTINTRAVENOUS ADMINISTRATIONS OF MORPHINE TO RATS, The Journal of pharmacology and experimental therapeutics, 266(1), 1993, pp. 244-252